New educational feature explores the importance of early diagnosis, treatment options and informed patient decisions.
OncoBeta is pleased to share a new educational feature developed for BRIGITTE, one of Germany’s well-known women’s media brands, exploring the importance of recognising potential signs of non-melanoma skin cancer (NMSC) and understanding the treatment options available.
Titled “When a Small Spot Becomes Something More: Non-Melanoma Skin Cancer”, the article highlights how seemingly minor skin changes – such as persistent scaly patches, non-healing wounds or slowly growing nodules – may warrant assessment by a dermatologist.
The feature also explores the importance of individualised treatment decisions, particularly when skin cancers occur in visible or sensitive areas such as the face, ears, scalp and hands.
Alongside established surgical and non-surgical treatment approaches, the article discusses emerging clinical evidence for local cutaneous radioisotope therapy using rhenium-188, including findings from the prospective, international, multicentre Phase IV EPIC-Skin study.
Importantly, the feature reinforces that treatment decisions should consider the type and characteristics of the cancer, individual patient circumstances, potential side effects and the recommendations of a qualified healthcare professional.
Through educational initiatives such as this, OncoBeta continues to support greater awareness of non-melanoma skin cancer and informed conversations between patients and their treating clinicians.
This article is part of a paid media collaboration with Reflex Media. The feature is provided for general educational purposes and does not replace professional medical advice.